Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.260
-0.030 (-2.33%)
Nov 4, 2024, 4:00 PM EST - Market closed
Vivani Medical Employees
Vivani Medical had 44 employees as of December 31, 2023. The number of employees decreased by 6 or -12.00% compared to the previous year.
Employees
44
Change (1Y)
-6
Growth (1Y)
-12.00%
Revenue / Employee
n/a
Profits / Employee
-$550,068
Market Cap
69.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TELA Bio | 227 |
| Xtant Medical Holdings | 215 |
| Hyperfine | 131 |
| Prelude Therapeutics | 128 |
| Owlet | 76 |
| Modular Medical | 40 |
| Quince Therapeutics | 32 |
| Zentek | 24 |
VANI News
- 13 days ago - Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 - Business Wire
- 5 weeks ago - Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire
- 6 weeks ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024 - Business Wire
- 2 months ago - Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - Business Wire
- 2 months ago - Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 2 months ago - Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results - Business Wire
- 4 months ago - Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 - Business Wire
- 5 months ago - Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant - Business Wire